<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Saturday Evening Post &#187; Clinical trial</title>
	<atom:link href="http://www.saturdayeveningpost.com/topics/clinical-trial/feed" rel="self" type="application/rss+xml" />
	<link>http://www.saturdayeveningpost.com</link>
	<description>Home of The Saturday Evening Post</description>
	<lastBuildDate>Fri, 24 May 2013 20:42:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5</generator>
		<item>
		<title>The Top Cancer Research Advancements of 2008</title>
		<link>http://www.saturdayeveningpost.com/2008/12/31/health-and-family/medical-update/top-cancer-research-advancements-2008.html?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=top-cancer-research-advancements-2008</link>
		<comments>http://www.saturdayeveningpost.com/2008/12/31/health-and-family/medical-update/top-cancer-research-advancements-2008.html#comments</comments>
		<pubDate>Wed, 31 Dec 2008 17:04:00 +0000</pubDate>
		<dc:creator>Wendy Braun</dc:creator>
				<category><![CDATA[Medical Update]]></category>
		<category><![CDATA[American Society of Clinical Oncology]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical trial]]></category>
		<category><![CDATA[Conditions and Diseases]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Life and Wellness]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>

		<guid isPermaLink="false">http://72.3.135.59/wordpress/?p=971</guid>
		<description><![CDATA[<p>The American Society of Clinical Oncology (ASCO) recently reported major scientific advances in the following areas: new therapy options for hard-to-treat lung and pancreatic cancers; FDA drug approvals for women with advanced breast cancer that does not express the HER2 gene (the majority of breast cancers) and people with chronic lymphocytic leukemia (a cancer with [...]</p><p><a href="http://www.saturdayeveningpost.com/2008/12/31/health-and-family/medical-update/top-cancer-research-advancements-2008.html">The Top Cancer Research Advancements of 2008</a>

<a href="http://www.saturdayeveningpost.com">The Saturday Evening Post</a></p>]]></description>
				<content:encoded><![CDATA[<p>The American Society of Clinical Oncology (ASCO) recently reported major scientific advances in the following areas: new therapy options for hard-to-treat lung and pancreatic cancers; FDA drug approvals for women with advanced breast cancer that does not express the HER2 gene (the majority of breast cancers) and people with chronic lymphocytic leukemia (a cancer with few treatments); reducing recurrence of breast and skin cancers; personalized cancer medicine; reducing cancer risk; and improving access to care. The 2008 ASCO annual progress report, developed by an editorial board of leading cancer specialists, also includes two recommendations to policymakers to accelerate progress against cancer: increase cancer research funding and improve access to clinical trials.</p>
<p>For details about each research advancement, visit <a href="http://cancer.net/">cancer.net</a></p>
<p><a href="http://www.saturdayeveningpost.com/2008/12/31/health-and-family/medical-update/top-cancer-research-advancements-2008.html">The Top Cancer Research Advancements of 2008</a>

<a href="http://www.saturdayeveningpost.com">The Saturday Evening Post</a></p>]]></content:encoded>
			<wfw:commentRss>http://www.saturdayeveningpost.com/2008/12/31/health-and-family/medical-update/top-cancer-research-advancements-2008.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
